🔎 Trials Near Me

Utama › COPD › Florida › Miami

Kajian klinikal COPD di Miami, FL

18 kajian untuk COPD sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Mengambil pesertaFasa 3
  • Research Site, Miami
  • Research Site, Miami
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Mengambil pesertaFasa 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • dan 3 lagi
Umur 40 hingga 80 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Mengambil pesertaFasa 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Umur 40 hingga 85 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07684820

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
Umur 40 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07780656

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Mengambil pesertaFasa 2
  • Millennium Medical Research - Miami, Miami
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Mengambil pesertaFasa 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • dan 1 lagi
Umur 40 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07190209

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Mengambil pesertaFasa 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Umur 40 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Mengambil pesertaFasa 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • dan 2 lagi
Umur 40 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Mengambil pesertaFasa 3
  • Research Site, Miami
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Mengambil pesertaFasa 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Mengambil pesertaFasa 2/3
  • Reed Medical Research, Miami
Umur 35 hingga 80 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

Mengambil pesertaFasa 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Umur 18 hingga 85 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07705737

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Umur 40 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Mengambil peserta
  • University of Miami, Miami
Umur 18 hingga 100 · Semua jantina · Dikemas kini 22 Jun 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 4 lagi
Umur 40 hingga 80 · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
Umur 40 hingga 80 · Semua jantina · Dikemas kini 8 Okt 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Mengambil peserta
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Umur 30 ke atas · Semua jantina · Dikemas kini 6 Feb 2025 · NCT05204888

Kajian COPD di bandar lain

Kajian lain di Miami

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.